Skip to main content
News Gregor Hagelüken 08.2022
PD Dr. Gregor Hagelueken (left) Dr. Martin Peter (right)
© Johann Saba / UKB

News categories: Publication

Structure of periplasmic TRAP transporter revealed

Elevator Tripartite ATP-independent periplasmic (TRAP) transporter shows a monomeric elevator architecture

Elevator Tripartite ATP-independent periplasmic (TRAP) transporters are found among various bacteria and archaea. They are situated in the periplasmic space and act as transport proteins for organic acids and related molecules. Though TRAP transporters are known to harbor two transmembrane domains and one soluble substrate-binding protein domain, until now the exact molecular structure remained elusive. Scientists of the excellence cluster ImmunoSensation2 at the University of Bonn in cooperation with colleagues of the University of York have now identified the structure of the TRAP transporter HiSiaQM. A functional analysis further revealed potential target areas for transporter inhibition. The study has now been published in the journal Nature Communications.

TRAP transporters help pathogens such as Haemophilus influenzae or Vibrio cholerae to evade the immune system. Sialic acid, which is ubiquitous in human tissue, is taken up by the pathogens via TRAP transporters. Subsequently, the organic acid is incorporated into the bacterial cell wall. "There, it serves as a kind of invisibility cloak for the bacteria to hide from our immune system," says Bonn scientist PD Dr Gregor Hagelueken. The pathogens mimic the surface of endogenous cells, where sialic acid frequently occurs in the form of cell surface glycoproteins.

The researchers from Hagelueken's group at the Institute of Structural Biology of the University Hospital Bonn (UKB) used cryo-electron microscopy (cryoEM) to decipher the structure of the transporter. "Our results represent a real breakthrough, since attempts to decipher the structure of a TRAP transporter had already been going on for about 20 years," says post-doctoral researcher Martin Peter from Bonn. He recalls the moment when it became clear that the monumental task had been accomplished: "At that moment, we were the first to ever see a TRAP transporter. It was then immediately clear to us how the protein works. It moves up and down like an elevator in the membrane.”

In collaboration with Prof. Dr. Ulrich Kubitscheck's group at the Clausius Institute for Physical and Theoretical Chemistry at the University of Bonn, the researchers were able to watch the transporter at work in real time. "The TRAP transporter is found in many disease-causing bacteria," says Hagelueken. "Maybe in the future our structure can help develop antibiotics to make sure the elevator gets stuck." The scientists were also able to generate several single variable domains on heavy chain (VHH) antibodies, binding to the periplasmic side of the TRAP transporter with high affinity. Application of the VHHs effectively inhibited the uptake of sialic acid. These insights into the functional mechanisms of TRAP transporter might help designing inhibitors for therapeutical use in the future.


Publication

Martin F. Peter, Jan A. Ruland, Peer Depping, Niels Schneberger, Emmanuele Severi, Jonas Moecking, Karl Gatterdam, Sarah Tindall, Alexandre Durand, Veronika Heinz, Jan Peter Siebrasse, Paul-Albert Koenig, Matthias Geyer, Christine Ziegler, Ulrich Kubitscheck, Gavin H. Thomas & Gregor Hagelueken: Structural and mechanistic analysis of a tripartite ATP-independent periplasmic TRAP transporter; Nature Communications; https://www.nature.com/articles/s41467-022-31907-y


Contact

PD Dr. Gregor Hagelueken

Institute for Structural Biology

University Hospital Bonn

Phone: +49 228 287-51200

Email: hagelueken(at)uni-bonn.de

Related news

Neurons - generated through the differentiation of induced neural stem cells (iNSCs) derived from blood.

News categories: Publication

Researchers Transform Old Blood Cells into Young Brain Cells

—Researchers from the University Hospital of Bonn and the University of Bonn have succeeded in dramatically rejuvenating human cells in a test tube. To do so, they directly reprogrammed red blood cell precursors into stem cells from which neurons can be derived. During this process, the molecular clocks that indicate a cell’s age were reset. For example, blood cells from an 80-year-old were transformed into stem cells with a molecular age of less than 20 years. The results have been published in the journal Aging Cell.
View entry
Dr. Robert Hüneburg, Dr. Anne-Sophie Layritz, and Nicola Reents (from left) - conducted a survey and found that fewer than one in ten people with Lynch syndrome take Acetylsalicylic acid for cancer prevention – despite a high level of openness to new preventive approaches.

News categories: Publication

Aspirin Rarely Used for Colorectal Cancer Prevention

—According to international studies, taking Acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer – even at low doses. Researchers from the University Hospital Bonn (UKB), the University of Bonn, and the Center for Integrated Oncology (CIO) Bonn, in collaboration with the self-help organization SemiColon, have now found that these scientific findings have so far been insufficiently incorporated into clinical practice. The results of the LYNX study have now been published as a letter in the journal The Lancet Gastroenterology & Hepatology.
View entry
Smartphone-based retinal imaging in clinical practice in India: - The image was taken during a collaborative project between University Hospital Bonn (UKB) and Sankara Eye Foundation India on smartphone-based telemedical screening for diabetic retinopathy.

News categories: Publication

Smartphones as Retinal Cameras: New Opportunities for Global Eye Care

—Smartphones could play an important role in the early detection of eye diseases, including in settings where specialized ophthalmic infrastructure is limited. An international team of experts led by the UKB and the University of Bonn has comprehensively reviewed the current global landscape of smartphone-based fundus imaging. The researchers highlight the technical and clinical possibilities that already exist today, identify the limitations of these methods, and outline the conditions that must be met so that smartphone-based retinal imaging can be more widely integrated into screening.
View entry

Back to the news overview